Retour aux projets

25598.2 PFNM-NM

Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

Résumé

Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

Textes supplémentaires

Abstract

The aim is to prevent impaired brain development in extreme and very preterm neonates in addition to reducing pain, infection risks, and to lowering costs for hospitals via continuous, non-invasive, transdermal, auto-calibrating glucose monitoring with passive diffusion. We developed, patented and tested in vitro a novel measurement principle with two parallel measurements for calibrating skin resistance. We now need to prove our new principle in a clinical pilot trial.

Participants

Martin Wolf

Kontaktperson

martin.wolf@usz.ch

USZ Universitätsspital Zürich Martin Wolf Frauenklinikstrasse 10 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-03-31
Date de fin
2018-12-31
Coûts totaux approuvés
CHF 150000.00
Section
22 Förderbereich Nano / Micro
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T171 Microelectronics 100.0%